These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9268085)

  • 1. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats.
    Kawasaki-Yatsugi S; Yatsugi S; Koshiya K; Shimizu-Sasamata M
    Jpn J Pharmacol; 1997 Jul; 74(3):253-60. PubMed ID: 9268085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils.
    Katsuta K; Umemura K; Ueyama N; Matsuoka N
    Eur J Pharmacol; 2003 Apr; 467(1-3):103-9. PubMed ID: 12706462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
    Yao H; Ibayashi S; Nakane H; Cai H; Uchimura H; Fujishima M
    Brain Res; 1997 Apr; 753(1):80-5. PubMed ID: 9125434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
    Umemura K; Shimakura A; Nakashima M
    Brain Res; 1997 Oct; 773(1-2):61-5. PubMed ID: 9409705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model.
    Gyertyán I; Gigler G; Simó A
    Brain Res Bull; 1999 Oct; 50(3):179-86. PubMed ID: 10566979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.
    O'Neill MJ; Bogaert L; Hicks CA; Bond A; Ward MA; Ebinger G; Ornstein PL; Michotte Y; Lodge D
    Neuropharmacology; 2000 Jul; 39(9):1575-88. PubMed ID: 10854902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M; Nielsen M; Rønn LC; Møller A; Noraberg J; Zimmer J
    Brain Res; 2007 Oct; 1177():124-35. PubMed ID: 17894933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potent AMPA/kainate receptor antagonist, YM90K, attenuates the loss of N-acetylaspartate in the hippocampal CA1 area after transient unilateral forebrain ischemia in gerbils.
    Nakano M; Ueda H; Li JY; Matsumoto M; Yanagihara T
    Life Sci; 2001 Sep; 69(17):1983-90. PubMed ID: 11589513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against post-ischaemic neuronal loss in gerbil hippocampal CA1 by glycineB and AMPA antagonists. Short communication.
    Lazarewicz JW; Gadamski R; Parsons CG; Danysz W
    J Neural Transm (Vienna); 1997; 104(11-12):1249-54. PubMed ID: 9503269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
    Takahashi M; Kohara A; Shishikura J; Kawasaki-Yatsugi S; Ni JW; Yatsugi S; Sakamoto S; Okada M; Shimizu-Sasamata M; Yamaguchi T
    CNS Drug Rev; 2002; 8(4):337-52. PubMed ID: 12481190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Shimizu-Sasamata M; Yatsugi S; Yamaguchi T
    J Pharm Pharmacol; 1998 Aug; 50(8):891-8. PubMed ID: 9751454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Shimizu-Sasamata M; Yamaguchi T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):586-91. PubMed ID: 9840429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.
    Ohno K; Okada M; Tsutsumi R; Sakamoto S; Yamaguchi T
    Jpn J Pharmacol; 1998 Jan; 76(1):105-8. PubMed ID: 9517411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.
    Wiard RP; Dickerson MC; Beek O; Norton R; Cooper BR
    Stroke; 1995 Mar; 26(3):466-72. PubMed ID: 7886726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of gamma-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils.
    Kakuda T; Yanase H; Utsunomiya K; Nozawa A; Unno T; Kataoka K
    Neurosci Lett; 2000 Aug; 289(3):189-92. PubMed ID: 10961661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
    Arias RL; Tasse JR; Bowlby MR
    Brain Res; 1999 Jan; 816(2):299-308. PubMed ID: 9878799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.
    Sheardown MJ; Suzdak PD; Nordholm L
    Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.